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Purpose: A glycocalyx plays important roles in the ocular surface epithelium, but there is no 
direct simple method to evaluate ocular surface glycocalyx. We tested a wheat germ aggluti-
nin conjugate of fluorescein (F-WGA) as a marker to demonstrate ocular surface glycocalyx 
in vivo.
Methods: After a 5% F-WGA solution was applied to the eyes of eight healthy volunteers, 
fluorescent intensities of the central cornea and bulbar conjunctiva were measured by fluoro-
photometry. A 10% fluorescein-conjugated dextran solution served as the control. Changes in 
fluorescent intensities of the ocular surface following a challenge with 5% N-acetyl cysteine, 
a conventional mucolytic agent, were tested in the second experiment. Saline instillation served 
as a control.
Results: The ocular surface was diffusely stained by F-WGA. Breakup of the precorneal 
tear film was not apparent, possibly because F-WGA was bound to the glycocalyx of the ocular 
surface epithelium. F-WGA fluorescent intensities were high in the superior, nasal, and inferior 
regions of the bulbar conjunctiva and low in the temporal conjunctiva and cornea. No such 
regional differences were observed with fluorescein-conjugated dextran. F-WGA fluorescent 
intensities decreased significantly with N-acetyl cysteine instillation, whereas they were not 
affected by saline instillation.
Conclusion: The fluorophotometric method may be used to evaluate the glycocalyx quantita-
tively in the ocular surface in vivo.
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Introduction
A glycocalyx, which consists of mucopolysaccharides and glycoproteins, is found 
on the apical portion of microvilli in corneal and conjunctival epithelia.1 Membrane-
associated mucins produced by apical cells are major components of the glycocalyx 
of the ocular surface epithelium.1–4 A glycocalyx plays important roles in ocular 
surface lubrication by maintaining wettability and eliminating foreign bodies and 
pathogens.1,5,6 Thus, the roles of glycocalyx-including mucins in the ocular surface 
have attracted attention.1–7
Several methods have been developed to evaluate ocular surface mucins. Rose 
bengal and lissamine green have been used clinically to determine epithelial dam-
age of the conjunctiva. Rose bengal stains ocular surface epithelial cells when they 
are not covered with mucins,7,8 whereas lissamine green stains membrane-damaged 
epithelial cells.9 Impression cytology is another technique that has been used for the 
analysis of ocular surface mucins. The density of goblet cells, mRNA expression of Clinical Ophthalmology 2010:4 submit your manuscript | www.dovepress.com
Dovepress 
Dovepress
926
Mochizuki et al
mucin genes, and alterations in glycosylation   characteristics 
of mucins have been analyzed using this technique.10–13 
Although recent advances in ocular surface mucins research 
are significant, the development of a simple and quantitative 
method to evaluate ocular surface glycocalyx will enable an 
improved understanding of the role of glycocalyx including 
mucins in the pathogenesis of ocular surface disorders.
In the present study, we tested a lectin conjugate of 
  fluorescein as a marker to demonstrate the presence of ocular 
surface glycocalyx in vivo. Lectins are a group of glycopro-
teins that bind specifically with carbohydrate residues of 
glycoconjugates.14 Of these, wheat germ agglutinin (WGA) 
specifically binds to N-acetyl glucosamine and N-acetyl 
neuraminic acid.14 A number of histochemical studies 
have demonstrated WGA binding to the ocular surface 
glycocalyx.15–20 In light microscopic studies, WGA has 
high affinity for apical cells of the corneal and conjunctival 
epithelium and for goblet cells in the conjunctiva.15–18 WGA 
binding to the glycocalyx of ocular surface cells has been 
confirmed by transmission electron microscopy.19,20 Based on 
these experimental studies,14–20 we used a WGA conjugate 
of fluorescein (F-WGA) to evaluate the glycocalyx in the 
ocular surface in vivo.
Subjects and methods
subjects
Eight healthy volunteers (five males and three females) aged 
27–46 years (33.4 ± 6.8 years, mean ± standard deviation 
[SD]) with no history of eye disease, except for refractive 
errors, were enrolled in the study. At the screening visit, one 
of the authors (MF) performed routine ocular examination 
of all subjects, followed by an examination of the ocular 
surface, including Schirmer testing and measurement of 
tear film breakup time. Saline solution (2 µL) containing 1% 
fluorescein was used for vital staining. All subjects had more 
than 5 mm of Schirmer strip wetting, more than five seconds 
in tear film breakup, and no apparent fluorescein staining of 
the cornea and conjunctiva. All subjects were diagnosed as 
normal according to the Japanese criteria for dry eye syn-
drome.21 The following experiments of F-WGA were done 
on subsequent investigation visits.
The guidelines of the World Medical Association Decla-
ration of Helsinki were followed. The subjects received a full 
explanation of the procedures and provided their informed 
consent for participation prior to the experiment. The protocol 
was approved by the institutional review board of National 
Tokyo Medical Center (R-07-011), and all subjects provided 
written informed consent.
Fluorescent dye and fluorophotometer
F-WGA (molecular weight 38,000 Da) and fluorescein-
conjugated dextran (molecular weight 40,000 Da) were 
purchased from Molecular Probes Inc. (Eugene, OR). Both 
dyes have their longest wavelength absorption maximum 
at 494 nm and an emission spectrum that peaks at 518 nm. 
A 10% F-WGA stock solution and a 10% fluorescein-
  conjugated dextran solution were prepared in sterile 0.067 M 
phosphate-buffered saline, pH 7.4.
A commercial slit-lamp fluorophotometer (Anterior 
Fluorometer FL-500, Kowa Co. Ltd., Tokyo, Japan) was 
used to quantify fluorescent intensity. The illuminating 
light was focused as a 2 mm diameter circle on the corneal 
surface. The emitted light passed through a band interfer-
ence filter centered on 565 nm (half bandwidth, 25 nm) 
and was directed to a photomultiplier tube with the band 
interference filter centered on a wavelength of 490 nm (half 
bandwidth, 30 nm).
A 10% F-WGA solution (100 mg/mL was diluted in 
phosphate-buffered saline to produce standards ranging from 
0.001% to 10% for calibration. A 10% fluorescein-conjugated 
dextran solution was diluted to produce standards ranging 
from 0.001% to 10% in the same manner. A cuvette was con-
structed by gluing together two microscopic slides and two 
cover glasses. The cover glasses were sandwiched by the two 
slides to provide a 12–15 µm thick space for the fluid layer. 
A fresh cuvette was used for each solution. The standards 
(10 µL) were added to the cuvettes, and fluorescence intensity 
was measured by slit-lamp fluorophotometer. The interaction 
of F-WGA or fluorescein-conjugated dextran with proteins 
was also tested by diluting the standards in phosphate-
buffered saline containing 10% fetal bovine serum.
staining characteristics of F-WgA
Preliminary experiments were conducted to determine the 
optimal concentration and time to observe F-WGA staining 
using four eyes from two subjects. Different concentrations 
of F-WGA solutions ranging from 1% to 10% were tested. 
A slit-lamp fluorophotometer was used to quantify the fluo-
rescent staining of the ocular surface. The instrument was 
focused on the central cornea and nasal bulbar conjunctiva 
3 mm posterior from the limbus, and the background fluo-
rescent intensity at each point was measured. A volume 
of 5 µL F-WGA solution was applied to the eye using an 
Eppendorf micropipette. The fluorescent intensities of the 
central cornea and nasal bulbar conjunctiva were measured 
for 30 minutes (every minute for the initial five minutes, and 
every five minutes from 5–30 minutes). Fluorescent   staining Clinical Ophthalmology 2010:4 submit your manuscript | www.dovepress.com
Dovepress 
Dovepress
927
Lectin-conjugated fluorescein
pattern was observed using a slit-lamp biomicroscope 
equipped with a blue-free barrier filter (SL-D7, Topcon 
Corp., Tokyo, Japan).22
Differences in fluorescent intensities  
by ocular surface regions
A slit-lamp fluorophotometer was used to quantify the 
fluorescent staining of the ocular surface. The subjects were 
seated in front of the fluorophotometer. The instrument was 
focused on the central cornea and eight quadrants (superior, 
superonasal, nasal, inferonasal, inferior, inferotemporal, 
temporal, and superotemporal) of the bulbar conjunctiva 
3 mm posterior to the limbus, and the background fluorescent 
intensity at each point was measured. A 5% F-WGA solu-
tion (5 µL) was applied to the right eye using an Eppendorf 
micropipette. Five minutes later, the fluorescent intensities 
of the central cornea and the eight quadrants of the bulbar 
conjunctiva were measured. The same procedure was per-
formed after application of 5 µL 10% fluorescein-conjugated 
dextran solution to the left eye.
Alteration of F-WgA staining  
by applying n-acetyl cysteine
The effect of N-acetyl cysteine, a conventionally used muco-
lytic agent, on F-WGA staining was tested.23 A 5% N-acetyl 
cysteine (Sigma-Aldrich, St Louis, MO) solution was pre-
pared in sterile 0.067 M phosphate-buffered saline, pH 7.4.
The background fluorescent intensities were   measured 
at the central cornea and four quadrants (superior, nasal, 
  inferior, and temporal) of the bulbar conjunctiva 3 mm 
posterior from the limbus. A volume of 5 µL of 5% F-WGA 
solution was applied to both eyes using an Eppendorf 
micropipette. Five minutes later, the fluorescent intensi-
ties of the central cornea and four quadrants of the bulbar 
conjunctiva were measured. A drop (20 µL) of 5% N-acetyl 
cysteine was instilled into the right eye using an   Eppendorf 
micropipette. A drop (20 µL) of saline (0.9% NaCl   solution) 
was instilled into the left eye in the same manner. The above-
mentioned procedure was repeated three times at   two-minute 
intervals. The fluorescent intensities of the central cornea 
and the four quadrants of the bulbar conjunctiva were 
then measured to identify the effects of N-acetyl cysteine 
challenge.
statistical methods
Data were analyzed using InStat 3 software (GraphPad 
Software, Inc., La Jolla, CA). The results are given as 
mean ± SD). The significance of the differences was analyzed 
with Kruskal-Wallis test or Wilcoxon matched pairs test. 
A P value , 0.05 was considered statistically significant.
Results
Fluorescent dye and fluorophotometer
We tested the safety profile of F-WGA using rabbit eyes, 
and then human eyes, although this material is not consid-
ered hazardous according to its material safety data sheet. 
No signs of inflammation or damage were detected either 
immediately or 24 hours after instilling five drops of 10% 
F-WGA solution at 10-minute intervals into the eyes of four 
rabbits. Instillation of one drop of 10% F-WGA solution into 
the eyes of four healthy subjects caused no discomfort, and 
no adverse effects were detected by a slit-lamp examination. 
From these preliminary experiments, a F-WGA solution 
below 10% was considered to have no apparent adverse 
effects on the ocular surface.
Fluorescent intensities of the standard dye solutions in 
cuvettes were measured by slit-lamp fluorophotometer. The 
relationship between fluorescent intensity and F-WGA con-
centration was linear (r2 = 0.986), and the data generated by 
this method were consistent and reproducible. Fluorescent 
intensity was unaffected by the presence of 10% fetal bovine 
serum. Similar results were obtained when the fluorescein-
conjugated dextran standards were tested (r2 = 0.978).
staining characteristics of F-WgA
Results of preliminary experiments using four eyes of 
two subjects to determine the optimal concentration and time 
to observe F-WGA staining are shown in Figures 1 and 2, 
respectively. The fluorescent intensities at the central cornea 
and nasal bulbar conjunctiva increased as the concentrations 
of F-WGA solution increased from 1% to 3%. However, 
they reached a plateau with F-WGA concentrations between 
3% and 10%. The fluorescent intensities at the central cornea 
and the nasal bulbar conjunctiva did not decay with time, 
and remained stable for 30 minutes after application of a 5% 
F-WGA solution. From these preliminary experiments, we 
selected a 5% F-WGA solution and the fluorophotometric 
measurement was performed five minutes after the applica-
tion. A 10% fluorescein-conjugated dextran solution was 
selected because it provided fluorescent intensities similar 
to that obtained on application of a 5% F-WGA solution 
to the eye.
The F-WGA staining patterns of the ocular surface 
observed using a slit-lamp biomicroscope equipped with a 
blue-free barrier filter are shown in Figure 3. F-WGA stained 
the corneal surface with a faint diffuse pattern. There was Clinical Ophthalmology 2010:4 submit your manuscript | www.dovepress.com
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Differences in fluorescent intensities 
by ocular surface regions
Fluorescent intensities five minutes after the applications 
of F-WGA and fluorescein-conjugated dextran are shown 
in Figures 4 and 5, respectively. Both dyes showed higher 
fluorescent intensities at the bulbar conjunctiva than at the 
central cornea. When fluorescein-conjugated dextran was 
applied, there were no differences in the fluorescent intensi-
ties of the bulbar conjunctiva regions. In contrast, F-WGA 
fluorescent intensities were high in the superior, nasal, 
and inferior regions of the bulbar conjunctiva, and low in 
the temporal region. Fluorescent intensities of F-WGA in 
the inferotemporal, temporal, and superotemporal regions 
were significantly lower than those in the superior region 
(P , 0.05, Kruskal-Wallis test).
Alteration of F-WgA staining  
by applying n-acetyl cysteine
Changes in fluorescent intensities by challenging with 
N-acetyl cysteine or saline are shown in Figures 6 and 7, 
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Figure 1 Plot of fluorescent intensities and wheat germ agglutinin conjugate of 
fluorescein (F-WGA) concentration. The fluorescent intensities at the central cornea 
and nasal bulbar conjunctiva increased as the concentrations of F-WgA solution 
increased from 1% to 3%. They reached a plateau with F-WgA concentrations 
between 3% and 10%.
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Figure 2 Plot of fluorescent intensities and time after application of 5% wheat germ 
agglutinin conjugate of fluorescein (F-WGA) solution. The fluorescent intensities 
of the central cornea and nasal bulbar conjunctiva were measured for 30 minutes. 
The fluorescent intensities at the central cornea and the nasal bulbar conjunctiva 
did not decay with time, and remained stable for 30 minutes after application of a 
5% F-WgA solution.
AB
Figure  3  staining  patterns  of  wheat  germ  agglutinin  conjugate  of  fluorescein 
(F-WGA) on the ocular surface observed using a slit-lamp biomicroscope equipped 
with a blue-free barrier filter. A) The corneal surface was stained by F-WGA with 
a faint, diffuse pattern. staining of the bulbar conjunctiva was more intense than the 
cornea. B) Tear mucus was strongly stained with F-WGA (arrows).
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Figure 4 Fluorescent intensities at the central cornea and eight quadrants of the bulbar 
conjunctiva after application of the wheat germ agglutinin conjugate of fluorescein 
(F-WGA). F-WGA showed higher fluorescent intensities at the bulbar conjunctiva 
than at the central cornea. F-WGA fluorescent intensities in the inferotemporal, 
temporal, and superotemporal regions of the bulbar conjunctiva were significantly 
lower than those in the superior region (P , 0.05, Kruskal–Wallis test).
no apparent break-up of the precorneal tear film as observed 
with fluorescein sodium, possibly because F-WGA was 
mainly bound to the corneal surface. Staining of the bulbar 
conjunctiva was more intense than the cornea, which had 
a diffuse but somewhat granular pattern. Tear mucus was 
strongly stained with F-WGA. These staining patterns were 
stable for at least 60 minutes, although the fluorescence was 
not detectable on the next day.Clinical Ophthalmology 2010:4 submit your manuscript | www.dovepress.com
Dovepress 
Dovepress
929
Lectin-conjugated fluorescein
respectively. The decrease in F-WGA fluorescent intensities 
at the cornea and the bulbar conjunctiva was statistically 
significant (P , 0.01 at the cornea and the nasal and inferior 
regions of the bulbar conjunctiva and P , 0.05 at the superior 
and temporal regions of the bulbar conjunctiva; Wilcoxon 
matched pairs test). F-WGA fluorescent intensities were not 
affected by instillation of saline.
Discussion
In the present study, we attempted to evaluate the ocular 
surface glycocalyx in vivo using F-WGA. Lectins, glyco-
proteins derived from plants and animals, have the unique 
ability to bind to specific glycoconjugate carbohydrates.14 
WGA is reported to bind to several specific carbohydrates, 
such as N-acetyl glucosamine and N-acetyl neuraminic acid.14 
No apparent break-up of the precorneal tear film appeared 
after application of the F-WGA solution. The F-WGA fluo-
rescent intensities at the central cornea and the nasal bulbar 
conjunctiva did not decay with time, at least for 30 minutes. 
Based on published histochemical studies that have inves-
tigated binding of lectins to the ocular surface,15–20 F-WGA 
appears to bind predominantly to the glycocalyx of the ocular 
surface epithelium.
N-acetyl cysteine is a classic mucolytic agent, which depo-
lymerizes the mucin glycoprotein oligomers by hydrolyzing the 
disulfide bonds that link the mucin monomers.23 Berry et al have 
recovered various types of mucins, including MUC1, MUC2, 
MUC4, and MUC5AC, from the ocular surface by washing 
with N-acetyl cysteine.23 In our study, F-WGA fluorescent 
intensities decreased dramatically after instilling N-acetyl 
cysteine, whereas they were not affected by saline instillation. 
As a result of the N-acetyl cysteine challenge, some parts of 
mucins, which are the major components of the glycocalyx, 
are removed from the ocular surface as shown by Berry et al.23 
These results appear to provide additional evidence suggesting 
that F-WGA binds to ocular surface glycocalyx.
F-WGA fluorescent intensities were higher in the superior, 
nasal, and inferior regions of the bulbar conjunctiva than 
in the temporal region. We used fluorescein-conjugated 
dextran, the molecular weight of which is similar to that of 
F-WGA. There were no differences in the fluorescent intensi-
ties in the bulbar conjunctiva regions when the fluorescein-
conjugated dextran was applied. Therefore, it is unlikely that 
the region-by-region differences in the barrier function of 
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Figure 5 Fluorescent intensities at the central cornea and eight quadrants of the 
bulbar conjunctiva after application of fluorescein-conjugated dextran. There were 
no regional differences in the conjunctiva with fluorescein-conjugated dextran.
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Figure 6 Fluorescent intensities of the wheat germ agglutinin conjugate of fluorescein 
(F-WGA) at the central cornea and four quadrants of the bulbar conjunctiva before 
and after a challenge with N-acetyl cysteine. The decrease in F-WGA fluorescent 
intensities  at  the  cornea  and  the  bulbar  conjunctiva  was  statistically  significant 
(*P , 0.01 at the cornea and the nasal and inferior regions of the bulbar conjunctiva 
and **P , 0.05 at the superior and temporal regions of the bulbar conjunctiva; 
Wilcoxon matched pairs test).
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Figure  7  Fluorescent  intensities  of  the  wheat  germ  agglutinin  conjugate  of 
fluorescein  (F-WGA)  at  the  central  cornea  and  four  quadrants  of  the  bulbar 
conjunctiva before and after a saline challenge. F-WGA fluorescent intensities were 
not affected by saline instillation.Clinical Ophthalmology
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conjunctival epithelium are responsible for the difference in 
fluorescent intensities. Although the reason for the phenom-
enon is not clear, some researchers have reported that there 
are topographic differences in the distribution of conjuncti-
val goblet cells.24,25 Goblet cells densities are higher in the 
nasal conjunctiva than in the temporal region and higher in 
the palpebral conjunctiva than in the bulbar conjunctiva.24,25 
Light microscopy studies have shown that WGA has a high 
affinity for goblet cells in the conjunctiva.15,17 Topographic 
differences in F-WGA fluorescent intensities may reflect 
these topographic distributions in conjunctival goblet cells.
In conclusion, we evaluated ocular surface mucins using 
F-WGA. This fluorophotometric method appears to be prom-
ising and may enable us to evaluate ocular surface mucins 
quantitatively in vivo. The data presented were obtained 
from healthy adults. The clinical significance of F-WGA 
staining should be tested in subjects with various ocular 
surface disorders, such as dry eye, allergic conjunctivitis, and 
contact lens wear. Further investigations have been planned 
to clarify these issues.
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